Clinical trials
Thrombosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Recruiting | 9 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Edinburgh | 9 |
| Bristol-Myers Squibb | 6 |
| Bayer | 3 |
| Boston Scientific Corporation | 3 |
| Queen Mary University of London | 3 |
| Sanofi | 3 |
| Imperial College London | 2 |
| King's College Hospital NHS Trust | 2 |
| Mercator MedSystems, Inc. | 2 |
| Oxford University Hospitals NHS Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 55 |
| Pulmonary Embolism | 9 |
| Venous Thromboembolism | 9 |
| Myocardial Infarction | 8 |
| Venous Thrombosis | 8 |
| Cardiovascular Diseases | 6 |
| Stroke | 6 |
| Thromboembolism | 6 |
| Coronary Artery Disease | 4 |
| Embolism | 4 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.